AZTherapies

AZTherapies

Pharmaceutical Manufacturing

Boston, Massachusetts 1,956 followers

Targeting Neuroinflammation: The Common Thread of Neurodegenerative Disease Progression

About us

AZTherapies, Inc. is a private, late-stage clinical biopharmaceutical company developing treatments for devastating neurological conditions. We are using an innovative, multi-modal approach that recognizes neuro-inflammation as a root cause of neuro-degeneration, leveraging the ability of cromolyn, a small molecule with a well-characterized safety profile, to shift the brain’s innate immune cells from a pro-inflammatory to neuroprotective state. We are advancing a pipeline of candidates in Alzheimer's Disease, amyotrophic lateral sclerosis (ALS) and post-ischemic stroke cognitive impairment.

Industry
Pharmaceutical Manufacturing
Company size
11-50 employees
Headquarters
Boston, Massachusetts
Type
Privately Held
Founded
2011

Locations

  • Primary

    200 Clarendon Street

    17th Floor

    Boston, Massachusetts 02116, US

    Get directions

Employees at AZTherapies

Similar pages

Browse jobs

Funding

AZTherapies 8 total rounds

Last Round

Series unknown

US$ 14.8M

See more info on crunchbase